Stevens-Johnson syndrome following concurrent phenytoin and holocranial radiotherapy.
Goyal
Shikha
S
Department of Radiotherapy, All India Institute of Medical Sciences, New Delhi-110029, India. drshikhagoyal@gmail.com
Biswas
Ahitagni
A
Puri
Tarun
T
Mohanti
Bidhu K
BK
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications / Q000532:radiotherapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects*; D011878:Radiotherapy / Q000009:adverse effects*; D012640:Seizures / Q000209:etiology / Q000517:prevention & control; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000209:etiology*
D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D010672:Phenytoin; D003907:Dexamethasone